Ligand · MD7
MD7 · (2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide
MD7, (2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide (C19 H16 N2 O2, 304.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues…
- Component
- MD7
- Formula
- C19 H16 N2 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
MD7 in 2 structures; the first of them:
- 3G0X · Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 5 · MD7 A2 · binds TYR38, MET43, LEU46, GLN47, PRO52, ALA55, HIS56, ALA59 and 12 more
- 3G0X · Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 5 · MD7 A2 · binds TYR38, MET43, LEU46, GLN47, PRO52, ALA55, HIS56, ALA59 and 12 more
Residues it binds most
LEU 2, TYR 2, ALA 2, MET 2, PRO 2, THR 2, ARG 2, GLN 2, HIS 2, PHE 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.